These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21482482)

  • 1. Th17 and Treg balance in systemic sclerosis.
    Khoury SJ
    Clin Immunol; 2011 Jun; 139(3):231-2. PubMed ID: 21482482
    [No Abstract]   [Full Text] [Related]  

  • 2. Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis.
    Fenoglio D; Battaglia F; Parodi A; Stringara S; Negrini S; Panico N; Rizzi M; Kalli F; Conteduca G; Ghio M; De Palma R; Indiveri F; Filaci G
    Clin Immunol; 2011 Jun; 139(3):249-57. PubMed ID: 21419712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases.
    Fenoglio D; Bernuzzi F; Battaglia F; Parodi A; Kalli F; Negrini S; De Palma R; Invernizzi P; Filaci G
    Autoimmun Rev; 2012 Dec; 12(2):300-4. PubMed ID: 22634708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imbalance between T helper 17 and regulatory T cell subsets plays a significant role in the pathogenesis of systemic sclerosis.
    Mo C; Zeng Z; Deng Q; Ding Y; Xiao R
    Biomed Pharmacother; 2018 Dec; 108():177-183. PubMed ID: 30219674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th17/Treg imbalance in adult patients with minimal change nephrotic syndrome.
    Liu LL; Qin Y; Cai JF; Wang HY; Tao JL; Li H; Chen LM; Li MX; Li XM; Li XW
    Clin Immunol; 2011 Jun; 139(3):314-20. PubMed ID: 21450528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into CD4(+) T cell abnormalities in systemic sclerosis.
    Liu M; Wu W; Sun X; Yang J; Xu J; Fu W; Li M
    Cytokine Growth Factor Rev; 2016 Apr; 28():31-6. PubMed ID: 26724976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th17 and Foxp3(+) T regulatory cell dynamics and distribution in myelodysplastic syndromes.
    Bouchliou I; Miltiades P; Nakou E; Spanoudakis E; Goutzouvelidis A; Vakalopoulou S; Garypidou V; Kotoula V; Bourikas G; Tsatalas C; Kotsianidis I
    Clin Immunol; 2011 Jun; 139(3):350-9. PubMed ID: 21444247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of Egr-2 in autoimmune diseases.
    Zhang M; Wang Y; Wang JS; Liu J; Liu MM; Yang HB
    Inflammation; 2015; 38(3):972-7. PubMed ID: 25381473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis.
    Aricha R; Mizrachi K; Fuchs S; Souroujon MC
    J Autoimmun; 2011 Mar; 36(2):135-41. PubMed ID: 21193288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Level of Th17 cell and CD4(+);CD25(+); Foxp3(+); regulatory T cell in peripheral blood mononuclear cells of primary nephrotic syndrome in children].
    Wang L; Li Q; Wang LJ; Li X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Aug; 26(8):783-6. PubMed ID: 20619107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation.
    Carrión F; Nova E; Luz P; Apablaza F; Figueroa F
    Immunol Lett; 2011 Mar; 135(1-2):10-6. PubMed ID: 20888363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6: regulator of Treg/Th17 balance.
    Kimura A; Kishimoto T
    Eur J Immunol; 2010 Jul; 40(7):1830-5. PubMed ID: 20583029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmunity in 2009.
    Selmi C
    Autoimmun Rev; 2010 Oct; 9(12):795-800. PubMed ID: 20716447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skewed X chromosomal inactivation impacts T regulatory cell function in systemic sclerosis.
    Broen JC; Wolvers-Tettero IL; Geurts-van Bon L; Vonk MC; Coenen MJ; Lafyatis R; Radstake TR; Langerak AW
    Ann Rheum Dis; 2010 Dec; 69(12):2213-6. PubMed ID: 20699236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of oxidized low-density lipoprotein in breaking peripheral Th17/Treg balance in patients with acute coronary syndrome.
    Li Q; Wang Y; Chen K; Zhou Q; Wei W; Wang Y; Wang Y
    Biochem Biophys Res Commun; 2010 Apr; 394(3):836-42. PubMed ID: 20302843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity.
    Slobodin G; Ahmad MS; Rosner I; Peri R; Rozenbaum M; Kessel A; Toubi E; Odeh M
    Cell Immunol; 2010; 261(2):77-80. PubMed ID: 20096404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor cell activity in progressive systemic sclerosis.
    Krawitt EL; Holdstock G; Bland JH; Chastenay BF; Albertini RJ
    J Rheumatol; 1982; 9(2):263-7. PubMed ID: 6212678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyses of T cell phenotype and function reveal an altered T cell homeostasis in systemic sclerosis. Correlations with disease severity and phenotypes.
    Giovannetti A; Rosato E; Renzi C; Maselli A; Gambardella L; Giammarioli AM; Palange P; Paoletti P; Pisarri S; Salsano F; Malorni W; Pierdominici M
    Clin Immunol; 2010 Oct; 137(1):122-33. PubMed ID: 20580318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma.
    Deleuran B; Abraham DJ
    Nat Clin Pract Rheumatol; 2007 Dec; 3(12):682-3. PubMed ID: 17848933
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantification and molecular characterization of regulatory T cells in connective tissue diseases.
    Banica L; Besliu A; Pistol G; Stavaru C; Ionescu R; Forsea AM; Tanaseanu C; Dumitrache S; Otelea D; Tamsulea I; Tanaseanu S; Chitonu C; Paraschiv S; Balteanu M; Stefanescu M; Matache C
    Autoimmunity; 2009 Jan; 42(1):41-9. PubMed ID: 18800250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.